Literature DB >> 8706674

Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules.

L Troeberg1, R N Pike, R E Morty, R K Berry, T H Coetzer, J D Lonsdale-Eccles.   

Abstract

African trypanosomes contain proteases that may be released into the bloodstream of their infected hosts. This paper describes a novel, combined isolation of a cysteine proteinase (called trypanopain-Tb) and a serine oligopeptidase (which we call oligopeptidase-Tb) from Trypanosoma brucei brucei, as well as a comparison of the activities of these two enzymes against several host regulatory molecules. The enzymes differed in various respects. Firstly, purified trypanopain-Tb was shown to readily cleave proteins such as gelatin maximally at acidic pH. In contrast, oligopeptidase-Tb, which is optimally active at alkaline pH, did not hydrolyse proteins larger than 4 kDa. However, it readily hydrolysed various polypeptides, including neurotensin and atrial natriuretic factor. The interaction of the two enzymes with mammalian protease inhibitors also differed. Cystatins and alpha2-macroglobulin effectively inhibited trypanopain-Tb, with the Ki values for cystatin C and low-molecular-mass kininogen (approximately 10(-11) M) predicting, that trypanopain-Tb is likely to be effectively controlled by these inhibitors if released into the host bloodstream. In contrast, oligopeptidase-Tb was not inhibited by serpins or (a2-macroglobulin, suggesting that it may remain active if released into the host bloodstream. In support of these in vitro results, the blood of trypanosome-infected rats displayed no trypanopain-Tb-like activity, but exhibited high oligopeptidase-Tb-like activity. Thus, while trypanopain-Tb seems likely to be confined to an intracellular role within the parasite, oligopeptidase-Tb has the potential to remain active in the host bloodstream and so contribute directly to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706674     DOI: 10.1111/j.1432-1033.1996.0728w.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei inhibit inflammatory pain in mice by targeting serotoninergic receptors.

Authors:  Rafaela Quintanilha Abrahão; Adriano Cardoso Franciosi; Douglas Andrade; Luiz Juliano; Maria Aparecida Juliano; Renata Giorgi; Camila Squarzoni Dale
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

3.  African Trypanosome-Induced Blood-Brain Barrier Dysfunction under Shear Stress May Not Require ERK Activation.

Authors:  Brandon J Sumpio; Gautham Chitragari; Takeshi Moriguchi; Sherif Shalaby; Valeria Pappas-Brown; Asif M Khan; Shamala Devi Sekaran; Bauer E Sumpio; Dennis J Grab
Journal:  Int J Angiol       Date:  2014-06-09

4.  Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.

Authors:  R E Morty; J D Lonsdale-Eccles; R Mentele; E A Auerswald; T H Coetzer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.

Authors:  Rory E Morty; Patrick Bulau; Roger Pellé; Sherwin Wilk; Koji Abe
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

6.  Oligopeptidase B deficient mutants of Leishmania major.

Authors:  Jane C Munday; Karen McLuskey; Elaine Brown; Graham H Coombs; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-09-29       Impact factor: 1.759

7.  Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.

Authors:  Jefferson P Hemerly; Vitor Oliveira; Elaine Del Nery; Rory E Morty; Norma W Andrews; Maria A Juliano; Luiz Juliano
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

8.  Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense.

Authors:  Carlos Mendoza-Palomares; Nicolas Biteau; Christiane Giroud; Virginie Coustou; Theresa Coetzer; Edith Authié; Alain Boulangé; Théo Baltz
Journal:  Eukaryot Cell       Date:  2008-02-15

9.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

10.  Modulation of the immunogenicity of the Trypanosoma congolense cysteine protease, congopain, through complexation with alpha(2)-macroglobulin.

Authors:  Laura Elizabeth Joan Huson; Edith Authié; Alain Francçois Boulangé; James Phillip Dean Goldring; Theresa Helen Taillefer Coetzer
Journal:  Vet Res       Date:  2009-06-24       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.